Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II
Phase of Trial: Phase I/II
Latest Information Update: 14 May 2018
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 15 Feb 2018 Planned End Date changed from 1 May 2027 to 1 May 2028.
- 22 May 2013 Status changed from not yet recruiting to recruiting as reported by M.D. Anderson Cancer Center.
- 22 May 2013 New source identified and integrated (M.D. Anderson Cancer Center: 2011-0283).